airway microbiota

Age, sex and lifestyle impact the upper airways microbiota

The findings suggest that the development and maturation of the nasal microbiota are influenced by age and sex, while lifestyle factors shape the throat microbiota.

The role of the microbiome in chronic lung disease

Aran Singanayagam, research group leader at Imperial College London (UK), examined how disturbances in the airway microbiome are instrumental in the development of chronic lung diseases.

Innovative partnership between Resilient Biotics and Cosmosid sets a new horizon in microbiome research

The two companies will work on identifying, analyzing, and understanding respiratory tract microbiome systems.

Lung bacteria may be associated with brain conditions after severe pneumonia

By suggesting that the bacteria detected in the brain after severe pneumonia originate from the lungs, the findings shed light onto the mechanisms of pneumonia-induced neurological conditions.

Microbiota signature may predict severe outcome of SARS-CoV-2 infection

The findings of a recent study suggest that, during SARS-CoV-2 infection, some bacteria in the upper airways’ microbiota may be associated with a person’s disease progression to intubation.

The respiratory microbiota could contribute to determine the severity of pneumonia

The findings suggest that the interplay between the respiratory tract microbiota, the levels of bacterial pathogens and specific clinical interventions is a key factor in determining the outcome of bacterial…

Accelerated lung function decline in chronic obstructive pulmonary disease (COPD): a role for airway dysbiosis

Airway dysbiosis was associated with a lung function decline in COPD patients and it might contribute to this phenotype through metabolic interaction with host pathophysiological processes.

COVID-19 in children: nasal microbiota as a possible ‘shield’ protection

Moraxella may be involved in protecting children from COVID-19 infections through its action on amino acid and lipid metabolism in the upper respiratory tract.

COVID-19 may alter lung microbiota and reduce immunity, facilitating secondary infections

COVID-19 alters the local immunity of the lung in ways that weaken the body’s antimicrobial defense and facilitate the development of secondary infections.

Bacterial signatures in gut and airway may be biomarker for COVID-19 severity

The findings of a new research suggest that changes in the microbial composition of people with COVID-19 could be used as a biomarker of invasion of lung pathogens and dysbiosis…

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top